Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting

The association between regorafenib dosage in the treatment of metastatic colorectal cancer (mCRC) and efficacy is currently not well established. It was previously reported that the regorafenib dose as prescribed is associated with efficacy, but doses in actual clinical settings have not been analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatori, Masahiro, Kawakami, Kazuyoshi, Wakatsuki, Takeru, Shinozaki, Eiji, Kobayashi, Kazuo, Aoyama, Takeshi, Nakano, Yasuhiro, Suzuki, Kenichi, Yamaguchi, Kensei, Hama, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524711/
https://www.ncbi.nlm.nih.gov/pubmed/34675759
http://dx.doi.org/10.1177/15593258211047658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524711/
https://www.ncbi.nlm.nih.gov/pubmed/34675759
http://dx.doi.org/10.1177/15593258211047658

Ejemplares similares